Keyphrases
2-median
20%
Acute Coronary Heart Disease
20%
AIMS™
20%
Apolipoprotein C-III
100%
Area under the Receiver Operating Characteristic Curve
40%
Atorvastatin
40%
Biomarker for Cardiovascular Disease
20%
Biomarker Panel
20%
Cardiovascular Disease
100%
Clinical Decision-making
20%
Clinical Trials
20%
Confidence Interval
60%
Cox Proportional Hazards Model
20%
Decision Selection
20%
Diabetes
20%
Early Discovery
20%
Framingham Risk Score
40%
Hazard Ratio
20%
Heart Stroke
20%
High-sensitivity Troponin T
40%
Incident Cardiovascular Disease
80%
Individual Performance
20%
Interleukin-15 (IL-15)
20%
Interleukin-6
20%
Joint Performance
20%
Model Prediction
20%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
80%
Natriuretic Peptides
100%
Overall Modeling
20%
Placebo
20%
Prohormone
100%
Risk Factors
20%
Risk Stratification
20%
Risk Variables
20%
Serum Samples
20%
Single Model
20%
Standardized Unit
20%
Type 2 Diabetes Mellitus (T2DM)
100%
Medicine and Dentistry
Amino Terminal Sequence
100%
Apolipoprotein C3
100%
Apoplexy
12%
Atorvastatin
25%
Biological Marker
62%
Brain Natriuretic Peptide
100%
Cardiovascular Disease
100%
Clinical Decision Making
12%
Clinical Trial
12%
Diabetes
12%
Framingham Risk Score
25%
Hazard Ratio
12%
Hormone Precursor
100%
Interleukin 15
12%
Interleukin 6
12%
Ischemic Heart Disease
12%
Maturity Onset Diabetes of the Young
100%
Placebo
12%
Proportional Hazards Model
12%
Risk Stratification
12%
Troponin T
25%
Nursing and Health Professions
Apolipoprotein C3
100%
Atorvastatin
25%
Biological Marker
62%
Brain Natriuretic Peptide
100%
Cardiovascular Disease
100%
Cerebrovascular Accident
12%
Clinical Decision Making
12%
Confidence Interval
37%
Framingham Risk Score
25%
Hazard Ratio
12%
Hormone Precursor
100%
Interleukin 15
12%
Interleukin 6
12%
Ischemic Heart Disease
12%
Non Insulin Dependent Diabetes Mellitus
100%
Placebo
12%
Proportional Hazards Model
12%
Receiver Operating Characteristic
25%
Troponin T
25%
Pharmacology, Toxicology and Pharmaceutical Science
Apolipoprotein C3
100%
Atorvastatin
25%
Biological Marker
62%
Brain Natriuretic Peptide
100%
Cardiovascular Disease
100%
Cerebrovascular Accident
12%
Clinical Trial
12%
Framingham Risk Score
25%
Hormone Precursor
100%
Interleukin 15
12%
Interleukin 6
12%
Ischemic Heart Disease
12%
Non Insulin Dependent Diabetes Mellitus
100%
Placebo
12%
Troponin T
25%
Biochemistry, Genetics and Molecular Biology
Apolipoprotein C3
100%
Atorvastatin
40%
Brain Natriuretic Peptide
100%
Clinical Decision Making
20%
Clinical Trial
20%
Interleukin 15
20%
Interleukin 6
20%
N-Terminus
100%
Troponin T
40%
Mathematics
Characteristic Curve
66%
Clinical Decision
33%
Confidence Interval
100%
Cox Proportional Hazards Model
33%
Hazard Ratio
33%
Median Age
33%